-

Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its third quarter 2025 financial results on Friday, November 7, 2025, and hold its conference call that morning at 8:00 am Eastern Time.

To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time.

To pre-register, go to the following link: https://www.netroadshow.com/events/login/LE9zwo3gtdzis7WZyrdvusEnWeMbZPm3F7y

A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck will also be available on this section of the Company’s website.

A replay of the conference call will be available after the call through the webcast archived on the Investor Relations section of the Company’s website.

About Claritev
Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by multiple data sources and over 40 years of claims repricing experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose–built solutions that support all key players – including payors, employers, patients, providers and third parties – Claritev aims to make healthcare more accessible and affordable for all. For more information, visit claritev.com.

Contacts

Investor Relations Contact
Todd Friedman
VP, Investor Relations
Claritev
866-909-7427
investor@claritev.com

Media Contact
Pamela Walker
VP, Corporate Marketing
Claritev
781-895-3118
press@claritev.com

Claritev Corporation

NYSE:CTEV
Details
Headquarters: McLean, VA
CEO: Travis Dalton
Employees: 2800
Organization: PUB

Release Summary
Claritev Corporation Announces Third Quarter 2025 Earnings Call
Release Versions

Contacts

Investor Relations Contact
Todd Friedman
VP, Investor Relations
Claritev
866-909-7427
investor@claritev.com

Media Contact
Pamela Walker
VP, Corporate Marketing
Claritev
781-895-3118
press@claritev.com

More News From Claritev Corporation

Claritev Corporation Announces Participation at Upcoming Conferences

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Participation at Upcoming Conferences...

Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”) at a price...

Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”). The...
Back to Newsroom